Jpmorgan Chase & CO Bionomics Limited Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Bionomics Limited stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1 shares of BNOX stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$4
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BNOX
# of Institutions
10Shares Held
2.5MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.59MShares$7.09 Million0.01% of portfolio
-
Lynx1 Capital Management LP San Juan, PR550KShares$2.45 Million0.09% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$1.41 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA34.1KShares$151,9140.0% of portfolio
-
Rhumbline Advisers Boston, MA8.3KShares$36,9350.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $33.5M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...